Objective To summarize the uric acid-lowering effects and mechanisms of Chinese medicines with medicine-food homology,aiming to provide novel perspectives for the devel-opment of new anti-hyperuricemia(HUA)drugs.Methods Papers on the research of HUA prevention and treatment with medicine-food ho-mology from December 15,2002 to August 10,2024 were screened and collected through Chi-na National Knowledge Infrastructure(CNKI),PubMed,ScienceDirect,and Google Scholar.Subsequently,the impact of these medications and their extracts,as well as the active com-pounds on HUA were assessed.Results A total of 148 relevant papers were collected,including 43 kinds of Chinese medicines and 61 active compounds,all of which have anti-HUA activity.Among them,41 kinds of Chinese medicines could inhibit the activity of xanthine oxidase,thus leading to the inhibition of uric acid production;and 22 kinds of Chinese medicines could facilitate uric acid excretion,while 15 kinds of Chinese medicines could reduce the inflammation levels in the body and promoting renal protection.Notably,polyphenols and flavonoids are the key active components for the uric acid-lowering effects.Conclusion This study systematically summarized and analyzed the uric acid-lowering ef-fects and mechanisms of Chinese medicines with medicine-food homology,laying a founda-tion for their development as HUA agents.

OBJECTIVETo assess the clinical value of single-port video-assisted thoracoscopic surgery (VATS) for treatment of pulmonary diseases.

METHODSFrom October, 2009 to December, 2013, 105 patients with pulmonary diseases were scheduled for single-pore VATS for pulmonary lobectomy (19 patients), wedge resection of the lung (34 patients), and bullae resection and pleurodesis for spontaneous pneumothorax or pulmonary bleb (52 patients).

RESULTSOf the 105 patients, 101 patients underwent single-port VATS; the procedure was converted to open thoracotomy in 1 patient and to conventional three-port VATS in 2 patients. The operative time was 50.6∓36.8 min (20-200 min) with intraoperative blood loss of 70∓56.9 ml (10-300 ml), thoracic drainage time of 4.2∓3.2 days (2-14 days), and postoperative hospital stay of 5.4∓3.8 days (3-16 days). Postoperative complications of the procedures included prolonged air leakage (6 cases) and atelectasis (2 cases). All the other patients recovered smoothly without serious complications.

CONCLUSIONSingle-port VATS is a safe and efficient procedure that allows rapid postoperative recovery and is a method of choice for selected patients with pulmonary diseases.

Humans ; Length of Stay ; Lung ; surgery ; Lung Diseases ; surgery ; Pneumothorax ; Postoperative Complications ; Postoperative Period ; Thoracic Surgery, Video-Assisted ; Thoracotomy